The FDA specifically took issue…
The FDA specifically took issue with the trial’s control arm, [...]
PharmaEssentia will spend $46…
PharmaEssentia will spend $46 million to build a manufacturing facility [...]
With Incyte set to lose patent…
With Incyte set to lose patent protection for its blood [...]
Nektar Therapeutics is basking in…
Nektar Therapeutics is basking in the honeyed glow of long-term [...]
Evommune has aced its first major…
Evommune has aced its first major test as a public [...]
AstraZeneca is taking its oral…
AstraZeneca is taking its oral GLP-1 drug into phase 3 [...]
A new campaign from Otsuka aims to…
A new campaign from Otsuka aims to educate healthcare professionals [...]
The agreement will see Phlow as…
The agreement will see Phlow as the first drugmaker to [...]
Hims & Hers caused a firestorm…
Hims & Hers caused a firestorm last week when it [...]
Eli Lilly has become the latest…
Eli Lilly has become the latest Big Pharma to buy [...]